Pharma & Healthcare
Global Recombinant Factor VIII Market Research Report 2025
- Sep 09, 25
- ID: 497195
- Pages: 81
- Figures: 83
- Views: 4
Report Scope
This report aims to provide a comprehensive presentation of the global market for Recombinant Factor VIII, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Recombinant Factor VIII.
The Recombinant Factor VIII market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Recombinant Factor VIII market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Recombinant Factor VIII manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Takeda
Bayer
CSL
Pfizer
Biogen
Octapharma
NovoNordisk
Segment by Type
200IU
250IU
Segment by Application
Hospital
Pharmacy
Consumption by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Europe
Germany
France
UK
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Recombinant Factor VIII manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Recombinant Factor VIII in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
This report aims to provide a comprehensive presentation of the global market for Recombinant Factor VIII, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Recombinant Factor VIII.
The Recombinant Factor VIII market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Recombinant Factor VIII market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Recombinant Factor VIII manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Takeda
Bayer
CSL
Pfizer
Biogen
Octapharma
NovoNordisk
Segment by Type
200IU
250IU
Segment by Application
Hospital
Pharmacy
Consumption by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Europe
Germany
France
UK
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Recombinant Factor VIII manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Recombinant Factor VIII in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
1 Recombinant Factor VIII Market Overview
1.1 Product Definition
1.2 Recombinant Factor VIII by Type
1.2.1 Global Recombinant Factor VIII Market Value Comparison by Type (2024 VS 2031)
1.2.2 200IU
1.2.3 250IU
1.3 Recombinant Factor VIII by Application
1.3.1 Global Recombinant Factor VIII Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Pharmacy
1.4 Global Recombinant Factor VIII Market Size Estimates and Forecasts
1.4.1 Global Recombinant Factor VIII Revenue 2020-2031
1.4.2 Global Recombinant Factor VIII Sales 2020-2031
1.4.3 Global Recombinant Factor VIII Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Recombinant Factor VIII Market Competition by Manufacturers
2.1 Global Recombinant Factor VIII Sales Market Share by Manufacturers (2020-2025)
2.2 Global Recombinant Factor VIII Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Recombinant Factor VIII Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Recombinant Factor VIII, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Recombinant Factor VIII, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Recombinant Factor VIII, Product Type & Application
2.7 Global Key Manufacturers of Recombinant Factor VIII, Date of Enter into This Industry
2.8 Global Recombinant Factor VIII Market Competitive Situation and Trends
2.8.1 Global Recombinant Factor VIII Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Recombinant Factor VIII Players Market Share by Revenue
2.8.3 Global Recombinant Factor VIII Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Recombinant Factor VIII Market Scenario by Region
3.1 Global Recombinant Factor VIII Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Recombinant Factor VIII Sales by Region: 2020-2031
3.2.1 Global Recombinant Factor VIII Sales by Region: 2020-2025
3.2.2 Global Recombinant Factor VIII Sales by Region: 2026-2031
3.3 Global Recombinant Factor VIII Revenue by Region: 2020-2031
3.3.1 Global Recombinant Factor VIII Revenue by Region: 2020-2025
3.3.2 Global Recombinant Factor VIII Revenue by Region: 2026-2031
3.4 North America Recombinant Factor VIII Market Facts & Figures by Country
3.4.1 North America Recombinant Factor VIII Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Recombinant Factor VIII Sales by Country (2020-2031)
3.4.3 North America Recombinant Factor VIII Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.4.6 Mexico
3.5 Europe Recombinant Factor VIII Market Facts & Figures by Country
3.5.1 Europe Recombinant Factor VIII Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Recombinant Factor VIII Sales by Country (2020-2031)
3.5.3 Europe Recombinant Factor VIII Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 UK
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Recombinant Factor VIII Market Facts & Figures by Region
3.6.1 Asia Pacific Recombinant Factor VIII Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Recombinant Factor VIII Sales by Region (2020-2031)
3.6.3 Asia Pacific Recombinant Factor VIII Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Recombinant Factor VIII Market Facts & Figures by Country
3.7.1 Latin America Recombinant Factor VIII Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Recombinant Factor VIII Sales by Country (2020-2031)
3.7.3 Latin America Recombinant Factor VIII Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Recombinant Factor VIII Market Facts & Figures by Country
3.8.1 Middle East and Africa Recombinant Factor VIII Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Recombinant Factor VIII Sales by Country (2020-2031)
3.8.3 Middle East and Africa Recombinant Factor VIII Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Recombinant Factor VIII Sales by Type (2020-2031)
4.1.1 Global Recombinant Factor VIII Sales by Type (2020-2025)
4.1.2 Global Recombinant Factor VIII Sales by Type (2026-2031)
4.1.3 Global Recombinant Factor VIII Sales Market Share by Type (2020-2031)
4.2 Global Recombinant Factor VIII Revenue by Type (2020-2031)
4.2.1 Global Recombinant Factor VIII Revenue by Type (2020-2025)
4.2.2 Global Recombinant Factor VIII Revenue by Type (2026-2031)
4.2.3 Global Recombinant Factor VIII Revenue Market Share by Type (2020-2031)
4.3 Global Recombinant Factor VIII Price by Type (2020-2031)
5 Segment by Application
5.1 Global Recombinant Factor VIII Sales by Application (2020-2031)
5.1.1 Global Recombinant Factor VIII Sales by Application (2020-2025)
5.1.2 Global Recombinant Factor VIII Sales by Application (2026-2031)
5.1.3 Global Recombinant Factor VIII Sales Market Share by Application (2020-2031)
5.2 Global Recombinant Factor VIII Revenue by Application (2020-2031)
5.2.1 Global Recombinant Factor VIII Revenue by Application (2020-2025)
5.2.2 Global Recombinant Factor VIII Revenue by Application (2026-2031)
5.2.3 Global Recombinant Factor VIII Revenue Market Share by Application (2020-2031)
5.3 Global Recombinant Factor VIII Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Takeda
6.1.1 Takeda Company Information
6.1.2 Takeda Description and Business Overview
6.1.3 Takeda Recombinant Factor VIII Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Takeda Recombinant Factor VIII Product Portfolio
6.1.5 Takeda Recent Developments/Updates
6.2 Bayer
6.2.1 Bayer Company Information
6.2.2 Bayer Description and Business Overview
6.2.3 Bayer Recombinant Factor VIII Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Bayer Recombinant Factor VIII Product Portfolio
6.2.5 Bayer Recent Developments/Updates
6.3 CSL
6.3.1 CSL Company Information
6.3.2 CSL Description and Business Overview
6.3.3 CSL Recombinant Factor VIII Sales, Revenue and Gross Margin (2020-2025)
6.3.4 CSL Recombinant Factor VIII Product Portfolio
6.3.5 CSL Recent Developments/Updates
6.4 Pfizer
6.4.1 Pfizer Company Information
6.4.2 Pfizer Description and Business Overview
6.4.3 Pfizer Recombinant Factor VIII Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Pfizer Recombinant Factor VIII Product Portfolio
6.4.5 Pfizer Recent Developments/Updates
6.5 Biogen
6.5.1 Biogen Company Information
6.5.2 Biogen Description and Business Overview
6.5.3 Biogen Recombinant Factor VIII Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Biogen Recombinant Factor VIII Product Portfolio
6.5.5 Biogen Recent Developments/Updates
6.6 Octapharma
6.6.1 Octapharma Company Information
6.6.2 Octapharma Description and Business Overview
6.6.3 Octapharma Recombinant Factor VIII Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Octapharma Recombinant Factor VIII Product Portfolio
6.6.5 Octapharma Recent Developments/Updates
6.7 NovoNordisk
6.7.1 NovoNordisk Company Information
6.7.2 NovoNordisk Description and Business Overview
6.7.3 NovoNordisk Recombinant Factor VIII Sales, Revenue and Gross Margin (2020-2025)
6.7.4 NovoNordisk Recombinant Factor VIII Product Portfolio
6.7.5 NovoNordisk Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Recombinant Factor VIII Industry Chain Analysis
7.2 Recombinant Factor VIII Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Recombinant Factor VIII Production Mode & Process Analysis
7.4 Recombinant Factor VIII Sales and Marketing
7.4.1 Recombinant Factor VIII Sales Channels
7.4.2 Recombinant Factor VIII Distributors
7.5 Recombinant Factor VIII Customer Analysis
8 Recombinant Factor VIII Market Dynamics
8.1 Recombinant Factor VIII Industry Trends
8.2 Recombinant Factor VIII Market Drivers
8.3 Recombinant Factor VIII Market Challenges
8.4 Recombinant Factor VIII Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Definition
1.2 Recombinant Factor VIII by Type
1.2.1 Global Recombinant Factor VIII Market Value Comparison by Type (2024 VS 2031)
1.2.2 200IU
1.2.3 250IU
1.3 Recombinant Factor VIII by Application
1.3.1 Global Recombinant Factor VIII Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Pharmacy
1.4 Global Recombinant Factor VIII Market Size Estimates and Forecasts
1.4.1 Global Recombinant Factor VIII Revenue 2020-2031
1.4.2 Global Recombinant Factor VIII Sales 2020-2031
1.4.3 Global Recombinant Factor VIII Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Recombinant Factor VIII Market Competition by Manufacturers
2.1 Global Recombinant Factor VIII Sales Market Share by Manufacturers (2020-2025)
2.2 Global Recombinant Factor VIII Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Recombinant Factor VIII Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Recombinant Factor VIII, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Recombinant Factor VIII, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Recombinant Factor VIII, Product Type & Application
2.7 Global Key Manufacturers of Recombinant Factor VIII, Date of Enter into This Industry
2.8 Global Recombinant Factor VIII Market Competitive Situation and Trends
2.8.1 Global Recombinant Factor VIII Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Recombinant Factor VIII Players Market Share by Revenue
2.8.3 Global Recombinant Factor VIII Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Recombinant Factor VIII Market Scenario by Region
3.1 Global Recombinant Factor VIII Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Recombinant Factor VIII Sales by Region: 2020-2031
3.2.1 Global Recombinant Factor VIII Sales by Region: 2020-2025
3.2.2 Global Recombinant Factor VIII Sales by Region: 2026-2031
3.3 Global Recombinant Factor VIII Revenue by Region: 2020-2031
3.3.1 Global Recombinant Factor VIII Revenue by Region: 2020-2025
3.3.2 Global Recombinant Factor VIII Revenue by Region: 2026-2031
3.4 North America Recombinant Factor VIII Market Facts & Figures by Country
3.4.1 North America Recombinant Factor VIII Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Recombinant Factor VIII Sales by Country (2020-2031)
3.4.3 North America Recombinant Factor VIII Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.4.6 Mexico
3.5 Europe Recombinant Factor VIII Market Facts & Figures by Country
3.5.1 Europe Recombinant Factor VIII Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Recombinant Factor VIII Sales by Country (2020-2031)
3.5.3 Europe Recombinant Factor VIII Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 UK
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Recombinant Factor VIII Market Facts & Figures by Region
3.6.1 Asia Pacific Recombinant Factor VIII Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Recombinant Factor VIII Sales by Region (2020-2031)
3.6.3 Asia Pacific Recombinant Factor VIII Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Recombinant Factor VIII Market Facts & Figures by Country
3.7.1 Latin America Recombinant Factor VIII Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Recombinant Factor VIII Sales by Country (2020-2031)
3.7.3 Latin America Recombinant Factor VIII Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Recombinant Factor VIII Market Facts & Figures by Country
3.8.1 Middle East and Africa Recombinant Factor VIII Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Recombinant Factor VIII Sales by Country (2020-2031)
3.8.3 Middle East and Africa Recombinant Factor VIII Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Recombinant Factor VIII Sales by Type (2020-2031)
4.1.1 Global Recombinant Factor VIII Sales by Type (2020-2025)
4.1.2 Global Recombinant Factor VIII Sales by Type (2026-2031)
4.1.3 Global Recombinant Factor VIII Sales Market Share by Type (2020-2031)
4.2 Global Recombinant Factor VIII Revenue by Type (2020-2031)
4.2.1 Global Recombinant Factor VIII Revenue by Type (2020-2025)
4.2.2 Global Recombinant Factor VIII Revenue by Type (2026-2031)
4.2.3 Global Recombinant Factor VIII Revenue Market Share by Type (2020-2031)
4.3 Global Recombinant Factor VIII Price by Type (2020-2031)
5 Segment by Application
5.1 Global Recombinant Factor VIII Sales by Application (2020-2031)
5.1.1 Global Recombinant Factor VIII Sales by Application (2020-2025)
5.1.2 Global Recombinant Factor VIII Sales by Application (2026-2031)
5.1.3 Global Recombinant Factor VIII Sales Market Share by Application (2020-2031)
5.2 Global Recombinant Factor VIII Revenue by Application (2020-2031)
5.2.1 Global Recombinant Factor VIII Revenue by Application (2020-2025)
5.2.2 Global Recombinant Factor VIII Revenue by Application (2026-2031)
5.2.3 Global Recombinant Factor VIII Revenue Market Share by Application (2020-2031)
5.3 Global Recombinant Factor VIII Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Takeda
6.1.1 Takeda Company Information
6.1.2 Takeda Description and Business Overview
6.1.3 Takeda Recombinant Factor VIII Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Takeda Recombinant Factor VIII Product Portfolio
6.1.5 Takeda Recent Developments/Updates
6.2 Bayer
6.2.1 Bayer Company Information
6.2.2 Bayer Description and Business Overview
6.2.3 Bayer Recombinant Factor VIII Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Bayer Recombinant Factor VIII Product Portfolio
6.2.5 Bayer Recent Developments/Updates
6.3 CSL
6.3.1 CSL Company Information
6.3.2 CSL Description and Business Overview
6.3.3 CSL Recombinant Factor VIII Sales, Revenue and Gross Margin (2020-2025)
6.3.4 CSL Recombinant Factor VIII Product Portfolio
6.3.5 CSL Recent Developments/Updates
6.4 Pfizer
6.4.1 Pfizer Company Information
6.4.2 Pfizer Description and Business Overview
6.4.3 Pfizer Recombinant Factor VIII Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Pfizer Recombinant Factor VIII Product Portfolio
6.4.5 Pfizer Recent Developments/Updates
6.5 Biogen
6.5.1 Biogen Company Information
6.5.2 Biogen Description and Business Overview
6.5.3 Biogen Recombinant Factor VIII Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Biogen Recombinant Factor VIII Product Portfolio
6.5.5 Biogen Recent Developments/Updates
6.6 Octapharma
6.6.1 Octapharma Company Information
6.6.2 Octapharma Description and Business Overview
6.6.3 Octapharma Recombinant Factor VIII Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Octapharma Recombinant Factor VIII Product Portfolio
6.6.5 Octapharma Recent Developments/Updates
6.7 NovoNordisk
6.7.1 NovoNordisk Company Information
6.7.2 NovoNordisk Description and Business Overview
6.7.3 NovoNordisk Recombinant Factor VIII Sales, Revenue and Gross Margin (2020-2025)
6.7.4 NovoNordisk Recombinant Factor VIII Product Portfolio
6.7.5 NovoNordisk Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Recombinant Factor VIII Industry Chain Analysis
7.2 Recombinant Factor VIII Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Recombinant Factor VIII Production Mode & Process Analysis
7.4 Recombinant Factor VIII Sales and Marketing
7.4.1 Recombinant Factor VIII Sales Channels
7.4.2 Recombinant Factor VIII Distributors
7.5 Recombinant Factor VIII Customer Analysis
8 Recombinant Factor VIII Market Dynamics
8.1 Recombinant Factor VIII Industry Trends
8.2 Recombinant Factor VIII Market Drivers
8.3 Recombinant Factor VIII Market Challenges
8.4 Recombinant Factor VIII Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Recombinant Factor VIII Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Recombinant Factor VIII Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Recombinant Factor VIII Market Competitive Situation by Manufacturers in 2024
Table 4. Global Recombinant Factor VIII Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Recombinant Factor VIII Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Recombinant Factor VIII Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Recombinant Factor VIII Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Recombinant Factor VIII Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Recombinant Factor VIII, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Recombinant Factor VIII, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Recombinant Factor VIII, Product Type & Application
Table 12. Global Key Manufacturers of Recombinant Factor VIII, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Recombinant Factor VIII by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant Factor VIII as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Recombinant Factor VIII Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Recombinant Factor VIII Sales by Region (2020-2025) & (K Units)
Table 18. Global Recombinant Factor VIII Sales Market Share by Region (2020-2025)
Table 19. Global Recombinant Factor VIII Sales by Region (2026-2031) & (K Units)
Table 20. Global Recombinant Factor VIII Sales Market Share by Region (2026-2031)
Table 21. Global Recombinant Factor VIII Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Recombinant Factor VIII Revenue Market Share by Region (2020-2025)
Table 23. Global Recombinant Factor VIII Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Recombinant Factor VIII Revenue Market Share by Region (2026-2031)
Table 25. North America Recombinant Factor VIII Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Recombinant Factor VIII Sales by Country (2020-2025) & (K Units)
Table 27. North America Recombinant Factor VIII Sales by Country (2026-2031) & (K Units)
Table 28. North America Recombinant Factor VIII Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Recombinant Factor VIII Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Recombinant Factor VIII Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Recombinant Factor VIII Sales by Country (2020-2025) & (K Units)
Table 32. Europe Recombinant Factor VIII Sales by Country (2026-2031) & (K Units)
Table 33. Europe Recombinant Factor VIII Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Recombinant Factor VIII Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Recombinant Factor VIII Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Recombinant Factor VIII Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Recombinant Factor VIII Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Recombinant Factor VIII Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Recombinant Factor VIII Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Recombinant Factor VIII Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Recombinant Factor VIII Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Recombinant Factor VIII Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Recombinant Factor VIII Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Recombinant Factor VIII Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Recombinant Factor VIII Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Recombinant Factor VIII Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Recombinant Factor VIII Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Recombinant Factor VIII Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Recombinant Factor VIII Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Recombinant Factor VIII Sales (K Units) by Type (2020-2025)
Table 51. Global Recombinant Factor VIII Sales (K Units) by Type (2026-2031)
Table 52. Global Recombinant Factor VIII Sales Market Share by Type (2020-2025)
Table 53. Global Recombinant Factor VIII Sales Market Share by Type (2026-2031)
Table 54. Global Recombinant Factor VIII Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Recombinant Factor VIII Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Recombinant Factor VIII Revenue Market Share by Type (2020-2025)
Table 57. Global Recombinant Factor VIII Revenue Market Share by Type (2026-2031)
Table 58. Global Recombinant Factor VIII Price (USD/Unit) by Type (2020-2025)
Table 59. Global Recombinant Factor VIII Price (USD/Unit) by Type (2026-2031)
Table 60. Global Recombinant Factor VIII Sales (K Units) by Application (2020-2025)
Table 61. Global Recombinant Factor VIII Sales (K Units) by Application (2026-2031)
Table 62. Global Recombinant Factor VIII Sales Market Share by Application (2020-2025)
Table 63. Global Recombinant Factor VIII Sales Market Share by Application (2026-2031)
Table 64. Global Recombinant Factor VIII Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Recombinant Factor VIII Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Recombinant Factor VIII Revenue Market Share by Application (2020-2025)
Table 67. Global Recombinant Factor VIII Revenue Market Share by Application (2026-2031)
Table 68. Global Recombinant Factor VIII Price (USD/Unit) by Application (2020-2025)
Table 69. Global Recombinant Factor VIII Price (USD/Unit) by Application (2026-2031)
Table 70. Takeda Company Information
Table 71. Takeda Description and Business Overview
Table 72. Takeda Recombinant Factor VIII Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 73. Takeda Recombinant Factor VIII Product
Table 74. Takeda Recent Developments/Updates
Table 75. Bayer Company Information
Table 76. Bayer Description and Business Overview
Table 77. Bayer Recombinant Factor VIII Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 78. Bayer Recombinant Factor VIII Product
Table 79. Bayer Recent Developments/Updates
Table 80. CSL Company Information
Table 81. CSL Description and Business Overview
Table 82. CSL Recombinant Factor VIII Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. CSL Recombinant Factor VIII Product
Table 84. CSL Recent Developments/Updates
Table 85. Pfizer Company Information
Table 86. Pfizer Description and Business Overview
Table 87. Pfizer Recombinant Factor VIII Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. Pfizer Recombinant Factor VIII Product
Table 89. Pfizer Recent Developments/Updates
Table 90. Biogen Company Information
Table 91. Biogen Description and Business Overview
Table 92. Biogen Recombinant Factor VIII Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. Biogen Recombinant Factor VIII Product
Table 94. Biogen Recent Developments/Updates
Table 95. Octapharma Company Information
Table 96. Octapharma Description and Business Overview
Table 97. Octapharma Recombinant Factor VIII Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. Octapharma Recombinant Factor VIII Product
Table 99. Octapharma Recent Developments/Updates
Table 100. NovoNordisk Company Information
Table 101. NovoNordisk Description and Business Overview
Table 102. NovoNordisk Recombinant Factor VIII Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 103. NovoNordisk Recombinant Factor VIII Product
Table 104. NovoNordisk Recent Developments/Updates
Table 105. Key Raw Materials Lists
Table 106. Raw Materials Key Suppliers Lists
Table 107. Recombinant Factor VIII Distributors List
Table 108. Recombinant Factor VIII Customers List
Table 109. Recombinant Factor VIII Market Trends
Table 110. Recombinant Factor VIII Market Drivers
Table 111. Recombinant Factor VIII Market Challenges
Table 112. Recombinant Factor VIII Market Restraints
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
Table 116. Authors List of This Report
List of Figures
Figure 1. Product Picture of Recombinant Factor VIII
Figure 2. Global Recombinant Factor VIII Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Recombinant Factor VIII Market Share by Type: 2024 & 2031
Figure 4. 200IU Product Picture
Figure 5. 250IU Product Picture
Figure 6. Global Recombinant Factor VIII Market Value by Application (2020-2031) & (US$ Million)
Figure 7. Global Recombinant Factor VIII Market Share by Application: 2024 & 2031
Figure 8. Hospital
Figure 9. Pharmacy
Figure 10. Global Recombinant Factor VIII Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 11. Global Recombinant Factor VIII Market Size (2020-2031) & (US$ Million)
Figure 12. Global Recombinant Factor VIII Sales (2020-2031) & (K Units)
Figure 13. Global Recombinant Factor VIII Average Price (USD/Unit) & (2020-2031)
Figure 14. Recombinant Factor VIII Report Years Considered
Figure 15. Recombinant Factor VIII Sales Share by Manufacturers in 2024
Figure 16. Global Recombinant Factor VIII Revenue Share by Manufacturers in 2024
Figure 17. Global 5 and 10 Largest Recombinant Factor VIII Players: Market Share by Revenue in Recombinant Factor VIII in 2024
Figure 18. Recombinant Factor VIII Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 19. Global Recombinant Factor VIII Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 20. North America Recombinant Factor VIII Sales Market Share by Country (2020-2031)
Figure 21. North America Recombinant Factor VIII Revenue Market Share by Country (2020-2031)
Figure 22. United States Recombinant Factor VIII Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 23. Canada Recombinant Factor VIII Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 24. Mexico Recombinant Factor VIII Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 25. Europe Recombinant Factor VIII Sales Market Share by Country (2020-2031)
Figure 26. Europe Recombinant Factor VIII Revenue Market Share by Country (2020-2031)
Figure 27. Germany Recombinant Factor VIII Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. France Recombinant Factor VIII Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. UK Recombinant Factor VIII Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Italy Recombinant Factor VIII Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Russia Recombinant Factor VIII Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Asia Pacific Recombinant Factor VIII Sales Market Share by Region (2020-2031)
Figure 33. Asia Pacific Recombinant Factor VIII Revenue Market Share by Region (2020-2031)
Figure 34. China Recombinant Factor VIII Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Japan Recombinant Factor VIII Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. South Korea Recombinant Factor VIII Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. India Recombinant Factor VIII Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Australia Recombinant Factor VIII Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. China Taiwan Recombinant Factor VIII Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Indonesia Recombinant Factor VIII Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Thailand Recombinant Factor VIII Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Malaysia Recombinant Factor VIII Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Latin America Recombinant Factor VIII Sales Market Share by Country (2020-2031)
Figure 44. Latin America Recombinant Factor VIII Revenue Market Share by Country (2020-2031)
Figure 45. Mexico Recombinant Factor VIII Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Brazil Recombinant Factor VIII Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Argentina Recombinant Factor VIII Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Middle East and Africa Recombinant Factor VIII Sales Market Share by Country (2020-2031)
Figure 49. Middle East and Africa Recombinant Factor VIII Revenue Market Share by Country (2020-2031)
Figure 50. Turkey Recombinant Factor VIII Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Saudi Arabia Recombinant Factor VIII Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. UAE Recombinant Factor VIII Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Global Sales Market Share of Recombinant Factor VIII by Type (2020-2031)
Figure 54. Global Revenue Market Share of Recombinant Factor VIII by Type (2020-2031)
Figure 55. Global Recombinant Factor VIII Price (USD/Unit) by Type (2020-2031)
Figure 56. Global Sales Market Share of Recombinant Factor VIII by Application (2020-2031)
Figure 57. Global Revenue Market Share of Recombinant Factor VIII by Application (2020-2031)
Figure 58. Global Recombinant Factor VIII Price (USD/Unit) by Application (2020-2031)
Figure 59. Recombinant Factor VIII Value Chain
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
Table 1. Global Recombinant Factor VIII Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Recombinant Factor VIII Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Recombinant Factor VIII Market Competitive Situation by Manufacturers in 2024
Table 4. Global Recombinant Factor VIII Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Recombinant Factor VIII Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Recombinant Factor VIII Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Recombinant Factor VIII Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Recombinant Factor VIII Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Recombinant Factor VIII, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Recombinant Factor VIII, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Recombinant Factor VIII, Product Type & Application
Table 12. Global Key Manufacturers of Recombinant Factor VIII, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Recombinant Factor VIII by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant Factor VIII as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Recombinant Factor VIII Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Recombinant Factor VIII Sales by Region (2020-2025) & (K Units)
Table 18. Global Recombinant Factor VIII Sales Market Share by Region (2020-2025)
Table 19. Global Recombinant Factor VIII Sales by Region (2026-2031) & (K Units)
Table 20. Global Recombinant Factor VIII Sales Market Share by Region (2026-2031)
Table 21. Global Recombinant Factor VIII Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Recombinant Factor VIII Revenue Market Share by Region (2020-2025)
Table 23. Global Recombinant Factor VIII Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Recombinant Factor VIII Revenue Market Share by Region (2026-2031)
Table 25. North America Recombinant Factor VIII Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Recombinant Factor VIII Sales by Country (2020-2025) & (K Units)
Table 27. North America Recombinant Factor VIII Sales by Country (2026-2031) & (K Units)
Table 28. North America Recombinant Factor VIII Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Recombinant Factor VIII Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Recombinant Factor VIII Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Recombinant Factor VIII Sales by Country (2020-2025) & (K Units)
Table 32. Europe Recombinant Factor VIII Sales by Country (2026-2031) & (K Units)
Table 33. Europe Recombinant Factor VIII Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Recombinant Factor VIII Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Recombinant Factor VIII Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Recombinant Factor VIII Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Recombinant Factor VIII Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Recombinant Factor VIII Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Recombinant Factor VIII Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Recombinant Factor VIII Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Recombinant Factor VIII Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Recombinant Factor VIII Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Recombinant Factor VIII Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Recombinant Factor VIII Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Recombinant Factor VIII Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Recombinant Factor VIII Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Recombinant Factor VIII Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Recombinant Factor VIII Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Recombinant Factor VIII Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Recombinant Factor VIII Sales (K Units) by Type (2020-2025)
Table 51. Global Recombinant Factor VIII Sales (K Units) by Type (2026-2031)
Table 52. Global Recombinant Factor VIII Sales Market Share by Type (2020-2025)
Table 53. Global Recombinant Factor VIII Sales Market Share by Type (2026-2031)
Table 54. Global Recombinant Factor VIII Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Recombinant Factor VIII Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Recombinant Factor VIII Revenue Market Share by Type (2020-2025)
Table 57. Global Recombinant Factor VIII Revenue Market Share by Type (2026-2031)
Table 58. Global Recombinant Factor VIII Price (USD/Unit) by Type (2020-2025)
Table 59. Global Recombinant Factor VIII Price (USD/Unit) by Type (2026-2031)
Table 60. Global Recombinant Factor VIII Sales (K Units) by Application (2020-2025)
Table 61. Global Recombinant Factor VIII Sales (K Units) by Application (2026-2031)
Table 62. Global Recombinant Factor VIII Sales Market Share by Application (2020-2025)
Table 63. Global Recombinant Factor VIII Sales Market Share by Application (2026-2031)
Table 64. Global Recombinant Factor VIII Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Recombinant Factor VIII Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Recombinant Factor VIII Revenue Market Share by Application (2020-2025)
Table 67. Global Recombinant Factor VIII Revenue Market Share by Application (2026-2031)
Table 68. Global Recombinant Factor VIII Price (USD/Unit) by Application (2020-2025)
Table 69. Global Recombinant Factor VIII Price (USD/Unit) by Application (2026-2031)
Table 70. Takeda Company Information
Table 71. Takeda Description and Business Overview
Table 72. Takeda Recombinant Factor VIII Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 73. Takeda Recombinant Factor VIII Product
Table 74. Takeda Recent Developments/Updates
Table 75. Bayer Company Information
Table 76. Bayer Description and Business Overview
Table 77. Bayer Recombinant Factor VIII Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 78. Bayer Recombinant Factor VIII Product
Table 79. Bayer Recent Developments/Updates
Table 80. CSL Company Information
Table 81. CSL Description and Business Overview
Table 82. CSL Recombinant Factor VIII Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. CSL Recombinant Factor VIII Product
Table 84. CSL Recent Developments/Updates
Table 85. Pfizer Company Information
Table 86. Pfizer Description and Business Overview
Table 87. Pfizer Recombinant Factor VIII Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. Pfizer Recombinant Factor VIII Product
Table 89. Pfizer Recent Developments/Updates
Table 90. Biogen Company Information
Table 91. Biogen Description and Business Overview
Table 92. Biogen Recombinant Factor VIII Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. Biogen Recombinant Factor VIII Product
Table 94. Biogen Recent Developments/Updates
Table 95. Octapharma Company Information
Table 96. Octapharma Description and Business Overview
Table 97. Octapharma Recombinant Factor VIII Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. Octapharma Recombinant Factor VIII Product
Table 99. Octapharma Recent Developments/Updates
Table 100. NovoNordisk Company Information
Table 101. NovoNordisk Description and Business Overview
Table 102. NovoNordisk Recombinant Factor VIII Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 103. NovoNordisk Recombinant Factor VIII Product
Table 104. NovoNordisk Recent Developments/Updates
Table 105. Key Raw Materials Lists
Table 106. Raw Materials Key Suppliers Lists
Table 107. Recombinant Factor VIII Distributors List
Table 108. Recombinant Factor VIII Customers List
Table 109. Recombinant Factor VIII Market Trends
Table 110. Recombinant Factor VIII Market Drivers
Table 111. Recombinant Factor VIII Market Challenges
Table 112. Recombinant Factor VIII Market Restraints
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
Table 116. Authors List of This Report
List of Figures
Figure 1. Product Picture of Recombinant Factor VIII
Figure 2. Global Recombinant Factor VIII Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Recombinant Factor VIII Market Share by Type: 2024 & 2031
Figure 4. 200IU Product Picture
Figure 5. 250IU Product Picture
Figure 6. Global Recombinant Factor VIII Market Value by Application (2020-2031) & (US$ Million)
Figure 7. Global Recombinant Factor VIII Market Share by Application: 2024 & 2031
Figure 8. Hospital
Figure 9. Pharmacy
Figure 10. Global Recombinant Factor VIII Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 11. Global Recombinant Factor VIII Market Size (2020-2031) & (US$ Million)
Figure 12. Global Recombinant Factor VIII Sales (2020-2031) & (K Units)
Figure 13. Global Recombinant Factor VIII Average Price (USD/Unit) & (2020-2031)
Figure 14. Recombinant Factor VIII Report Years Considered
Figure 15. Recombinant Factor VIII Sales Share by Manufacturers in 2024
Figure 16. Global Recombinant Factor VIII Revenue Share by Manufacturers in 2024
Figure 17. Global 5 and 10 Largest Recombinant Factor VIII Players: Market Share by Revenue in Recombinant Factor VIII in 2024
Figure 18. Recombinant Factor VIII Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 19. Global Recombinant Factor VIII Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 20. North America Recombinant Factor VIII Sales Market Share by Country (2020-2031)
Figure 21. North America Recombinant Factor VIII Revenue Market Share by Country (2020-2031)
Figure 22. United States Recombinant Factor VIII Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 23. Canada Recombinant Factor VIII Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 24. Mexico Recombinant Factor VIII Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 25. Europe Recombinant Factor VIII Sales Market Share by Country (2020-2031)
Figure 26. Europe Recombinant Factor VIII Revenue Market Share by Country (2020-2031)
Figure 27. Germany Recombinant Factor VIII Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. France Recombinant Factor VIII Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. UK Recombinant Factor VIII Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Italy Recombinant Factor VIII Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Russia Recombinant Factor VIII Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Asia Pacific Recombinant Factor VIII Sales Market Share by Region (2020-2031)
Figure 33. Asia Pacific Recombinant Factor VIII Revenue Market Share by Region (2020-2031)
Figure 34. China Recombinant Factor VIII Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Japan Recombinant Factor VIII Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. South Korea Recombinant Factor VIII Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. India Recombinant Factor VIII Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Australia Recombinant Factor VIII Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. China Taiwan Recombinant Factor VIII Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Indonesia Recombinant Factor VIII Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Thailand Recombinant Factor VIII Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Malaysia Recombinant Factor VIII Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Latin America Recombinant Factor VIII Sales Market Share by Country (2020-2031)
Figure 44. Latin America Recombinant Factor VIII Revenue Market Share by Country (2020-2031)
Figure 45. Mexico Recombinant Factor VIII Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Brazil Recombinant Factor VIII Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Argentina Recombinant Factor VIII Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Middle East and Africa Recombinant Factor VIII Sales Market Share by Country (2020-2031)
Figure 49. Middle East and Africa Recombinant Factor VIII Revenue Market Share by Country (2020-2031)
Figure 50. Turkey Recombinant Factor VIII Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Saudi Arabia Recombinant Factor VIII Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. UAE Recombinant Factor VIII Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Global Sales Market Share of Recombinant Factor VIII by Type (2020-2031)
Figure 54. Global Revenue Market Share of Recombinant Factor VIII by Type (2020-2031)
Figure 55. Global Recombinant Factor VIII Price (USD/Unit) by Type (2020-2031)
Figure 56. Global Sales Market Share of Recombinant Factor VIII by Application (2020-2031)
Figure 57. Global Revenue Market Share of Recombinant Factor VIII by Application (2020-2031)
Figure 58. Global Recombinant Factor VIII Price (USD/Unit) by Application (2020-2031)
Figure 59. Recombinant Factor VIII Value Chain
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Outdoor Shed Market Research Report 2025
Sep 09, 25
Global Residential Outdoor Cabinet Market Research Report 2025
Sep 09, 25
Global Outdoor Storage Cabinet Market Research Report 2025
Sep 09, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232